
ABOUT PROJECT FARMA
Project Farma is a patient-focused consulting firm committed to advancing manufacturing and speed-to-market for next-generation medicines. We provide biomanufacturing strategy and execution to startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, government agencies, financial institutions, CROs/CMOs, not-for-profit organizations and medical device companies. Our services include defining manufacturing and facility build strategy, capital project management, tech transfers and facility builds; owner's representation; project and program management; validation; quality; engineering and automation; reliability and compliance; and more.
Project Farma is a Precision for Medicine company and part of Precision ADVANCE, the cell & gene therapy collective™. Precision ADVANCE is a collection of interconnected services and complementary teams uniquely focused on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring a cell or gene therapy to market.
FEATURED SERVICES
-
Project Farma's engineering maintenance offering encompasses the complete asset management lifecycle (new and existing) starting with program and department creation.
-
Project Farma's professionals apply years of expertise to accomplish the most challenging engineering and automation tasks.
-
Learn how Project Farma has met the challenges in developing, implementing, and sustaining efficient, effective, and compliant quality management systems, policies and procedures, SOPs for both ISO certification and worldwide GMP compliance.
-
Our experienced validation team will document the consistency, quality, and accuracy of your systems, methods, and processes. We understand the different validation requirements for GMP, GLP, and GCP systems and the best ways to ensure compliance with FDA, EMA, and other global regulations.
-
Learn how Project Farma helps provide capital projects and facility builds, with the goal of having a finished GMP facility that comes in on-time, on-budget, and performs as expected and designed.
-
Project Farma has tremendous experience in providing business and manufacturing strategy to early-stage startups, established life science companies, leading medical institutions and CROs/CMOs. The team can not only help define and develop the strategy for our partners but also execute the strategy with confidence.
CONTACT INFORMATION
Project Farma
2 Bethesda Metro Center, Suite 850
Bethesda, MD 20814
UNITED STATES
Contact: Anshul Mangal, President
FEATURED ARTICLES
- Scaling Hope: Growth Of The Allogeneic Cell Therapy Sector
- Establishing The Right-Sized Tech Ops Strategy In An Uncertain Market
- A Step-By-Step Approach To Implementing Quality Infrastructure
- Single-Use, Stainless Steel, Or Both? Key Points To Consider
- Innovations In Gene Editing Provide Hope For Patients In Need
- Mind The Cell And Gene Gap
- Developing Market Access And Distribution Strategies In CAR T-Cell Therapy
- The Effect Of Public Markets On Manufacturing Cell & Gene Therapies
- The Future Of Cell Therapy Manufacturing
- Challenges And Innovation In Gene Therapy Manufacturing
- Improve Biopharmaceutical Manufacturing Outcomes With Data Integrity
- The Importance Of Validation Master Planning
- Manufacturing Considerations For Early-Stage Advanced Therapies
- Process And Communication: Navigating Logistical Complexity In Matched Cellular Therapy Trials
- A Shared Opportunity: The Future Of Cell And Gene Therapy
- Cell And Gene Therapies: Opportunities For Innovation
- Considerations For Clinical Development of Cell & Gene Therapies
- Considerations For Cell & Gene Therapy Clinical Development, Part 1
- Manufacturing Considerations When Developing Advanced Therapies
- Continuing The Conversation: The Future Of Reimbursement For Cell And Gene Therapies